TokenPost·
MapLight Therapeutics Posts $0.97 Q3 GAAP Loss Per Share, Beats Estimates

MapLight Therapeutics, Inc. had $463.4 million in cash, cash equivalents and investments as of Sept. 30.
Every crypto headline. One feed. Updated every minute.

MapLight Therapeutics, Inc. had $463.4 million in cash, cash equivalents and investments as of Sept. 30.